News

The "interactive modeler" will allow users to plug in their own assumptions.

A look at the president and CEO's experience in becoming an influential reason for Intermountain Healthcare's success.

Our roundup of PBMI2020 meeting so far

Isatuximab-irfc (Sarclisa, Sanofi-Aventis) was approved in combination with pomalidomide and dexamethason to treat adult patients with multiple myeloma who have received at least two prior therapies.

Inhaler is the first generic approval of its kind.

Michael Chernew and his coauthors say it is time to prune the proliferating number of payment reform models

A look at Shelbourn Stevens, president and COO at Novant Health Brunswick Medical Center and his career in healthcare.

The Leukemia & Lymphoma Society cautions consumers to be wary of short-term plans and urges state and federal policymakers to protect patients.

How electronic patient-reported outcome solutions can help democratize access to cancer care and improve experiences for patients and clinic care teams.

Leaders of OneOncology say Oncology Care First signals the future of value-based care

A week in review with Manage Healthcare Executive's most popular online articles for the week ending February 29, 2020. 

Rechtin takes the reins at Envision.

New Coverys Report identifies root causes of surgery-related claims and strategies to improve patient safety.

People are missing the point about social determinants of health

Three in 10 likely voters are concerned about health insurance, OOP costs.

131,000 Americans, ages 30-64, have a diagnoses

Radiologists at Mount Sinai say they have identified telltale patterns

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

Voice user interfaces could make healthcare more efficient and effective.

Casey Ross, national technology correspondent for STAT, explains during a February 13 webinar, the benefits of AI in healthcare and how it must demonstrably improve outcomes for patients.

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

USPSTF 'insufficient evidence' stance repeats 2014 recommendation

Treatment is first non-statin LDL-C lowering treatment approved in years.

Eisai disagrees with FDA decision.

News about UnitedHealth, Alkermes, M4A, and MA that you need to know about. 

When it comes to solving your revenue cycle management challenges, your solutions are closer than they appear.